Leaders in Pharmaceutical Business Intelligence (LPBI) Group

NIH to Award Up to $12M to Fund DNA, RNA Sequencing Research: single-cell genomics,  sample preparation,  transcriptomics and epigenomics, and  genome-wide functional analysis.

Reporter: Aviva Lev-Ari, PhD, RN

2.2.22   NIH to Award Up to $12M to Fund DNA, RNA Sequencing Research: single-cell genomics,  sample preparation, transcriptomics and epigenomics, and  genome-wide functional analysis, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 2: CRISPR for Gene Editing and DNA Repair

Details about the funding opportunities can be found here,here, here, and here.

Novel Genomic Technology Development (R01)

http://grants.nih.gov/grants/guide/pa-files/PAR-16-014.html

Novel Genomic Technology Development (R21)

http://grants.nih.gov/grants/guide/pa-files/PAR-16-015.html

Novel Genomic Technology Development -(R43/R44)

http://grants.nih.gov/grants/guide/pa-files/PAR-16-016.html

Novel Genomic Technology Development – Direct to Phase II SBIR Grant (R44)

http://grants.nih.gov/grants/guide/pa-files/PAR-16-017.html

NIH Announces Funding Opportunities for Novel Genomic Technology Development

Oct 27, 2015 |

a GenomeWeb staff reporter NEW YORK (GenomeWeb) –

The National Institutes of Health announced four new funding opportunities to support the development of innovative genomic technologies across a broad range of research areas including

• single-cell genomics,
• sample preparation,
• transcriptomics and epigenomics, and
• genome-wide functional analysis.

The money will be made available under the NIH’s standard research and exploratory/developmental research mechanisms, as well as in the form of Small Business Innovation Research grants. Get the full story This story is free for registered users Registering provides access to this and other free content.

Register now. Already have an account? Login Now. Related Articles Aug 17, 2015 NIH to Award Up to $12M to Fund DNA, RNA Sequencing Research

Examples of appropriate areas of research include the analysis of DNA, RNA, epigenome, and transcriptome data from the same biological sample; technologies for high-throughput genome modification; and measurement of proximal transcription dynamics, as well as transcription dynamics over time and from cells to organs.

The NIH said that the total amount available under the funding opportunities will depend on appropriations and the submission of a sufficient number of meritorious awards. However, it did provide guidance on the size of individual awards.

Grants awarded under the R01 mechanism may have direct costs up to $700,000 a year, with project periods up to four years. Under the R21 mechanism, projects may run for up to three years with direct costs of no more than $200,000 a year with funding for the entire budget period capped at $400,000.

Phase I and Phase II SBIR grants, including Direct to Phase II, are limited to $150,000 and $1 million in total funding, respectively. However, the NIH said that it has permission to exceed these caps for certain projects with appropriate justification.

“It is expected that awardees will develop scientific and practical definitions of optimal cost, quality, scale, and other important features enabling the significant genomics technology development proposed,” the NIH said. “Priority will be given to applications that propose improvements of at least an order of magnitude [and] … such improvements may be achieved by focusing on one critical factor or a combination of important ones.”

SOURCE

https://www.genomeweb.com/research-funding/nih-announces-funding-opportunities-novel-genomic-technology-development